Immunohistochemical (IHC) experiments further validate the high expression of MRPL15 in NSCLC and confirm its potential as a prognostic marker (60).The expression of MRPL9 is upregulated in lung cancer tissues and is associated with OS and RFS in patients (61). This evidence concerns the gene MRPL9 and lung carcinoma.